Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,380 | 180,527 | 181,330 | 177,757 | 82,586 |
| Marketable Securities | 247,502 | 267,278 | 245,125 | 224,829 | 150,393 |
| Receivables | 120,345 | 109,066 | 117,290 | 100,750 | 105,828 |
| Inventories | 135,822 | 128,695 | 120,825 | 120,125 | 124,064 |
| Income taxes - deferred | 29,474 | 32,356 | N/A | N/A | N/A |
| Other current assets | 35,501 | 25,509 | 54,816 | 58,073 | 50,519 |
| TOTAL | $723,024 | $743,431 | $719,386 | $681,534 | $513,390 |
| Non-Current Assets | |||||
| PPE Net | 281,865 | 284,473 | 273,724 | 267,374 | 264,317 |
| Investments And Advances | 124,498 | 117,073 | 107,589 | 123,155 | 55,833 |
| Intangibles | 226,991 | 214,523 | 217,167 | 219,810 | 222,457 |
| Other Non-Current Assets | 241,915 | 208,847 | 249,510 | 240,654 | 241,088 |
| TOTAL | $875,269 | $824,916 | $847,990 | $850,993 | $783,695 |
| Total Assets | $1,598,293 | $1,568,347 | $1,567,376 | $1,532,527 | $1,297,085 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 23,365 | 23,440 | 23,440 | 23,455 |
| Accounts payable and accrued liabilities | 144,008 | 147,068 | 111,489 | 96,557 | 96,359 |
| TOTAL | $144,008 | $170,433 | $134,929 | $119,997 | $119,814 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 166,612 | 382,151 | 417,253 | 412,104 | 405,321 |
| TOTAL | $204,133 | $382,151 | $417,253 | $412,104 | $405,321 |
| Total Liabilities | $348,141 | $552,584 | $552,182 | $532,101 | $525,135 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,010 | 126,102 | 123,826 | 123,555 | 115,701 |
| Common Shares | 139 | 126 | 124 | 123 | 116 |
| Retained earnings | -579,258 | -539,448 | -486,436 | -481,079 | -449,073 |
| Other shareholders' equity | -4,560 | -6,805 | -4,270 | -1,954 | -1,026 |
| TOTAL | $1,250,152 | $1,015,763 | $1,015,194 | $1,000,426 | $771,950 |
| Total Liabilities And Equity | $1,598,293 | $1,568,347 | $1,567,376 | $1,532,527 | $1,297,085 |